Clinical trial
REVEAL Registry™: Registry to Evaluate Early And Long-term PAH Disease…
NCT00370214 · Actelion, Industry · Completed
Key facts
| NCT number | NCT00370214 |
|---|---|
| Title | REVEAL Registry™: Registry to Evaluate Early And Long-term PAH Disease Management |
| Official title | REVEAL Registry™: Registry to Evaluate Early And Long-term PAH Disease Management |
| Lead sponsor | Actelion, Industry |
| Status | Completed |
| Study type | Observational |
| Conditions | Pulmonary Hypertension |
| Enrollment | 3,515 |
| Start date | Mar 1, 2006 |
| Primary completion | Dec 1, 2012 |
| Completion | Dec 1, 2012 |
| First posted | Aug 31, 2006 |
| Last update posted | May 17, 2013 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: